Effect of matrine on U937 cells and human umbilical vein endothelial cells proliferation
Zong-Gan Huang
Abstract
Zong-Gan Huang
Abstract
AIM:To observe the proliferative effects of matrine on U937 cells and human umbilical vein endothelial cells. METHODS: The effects of matrine on U937 cells and human umbilical vein endothelial cells proliferation were observed by morphology, MTT and cell cycle detection. RESULTS: U937 cells treated with matrine at the concentration of 0.2 mg/mL to 0.5 mg/mL for 24 h were inhibited proliferation in a time and dose-dependent manner detected by MTT (P0.05 or P0.01) and increased at the S stage (P0.05 or P0.01). The half-inhibition concentration (IC50) was 0.4 mg/mL in U937 cells compared with human umbilical vein endothelial cells (P0.05). HUVECs treated with matrine at the concentration of 0.1 to 0.5 mg/mL for 48 h showed no effect on cell cycle (P0.05). CONCLUSION: Matrine has an inhibited effect on U937 cells proliferation in a time and dose-dependent manner.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM:To observe the proliferative effects of matrine on U937 cells and human umbilical vein endothelial cells. METHODS: The effects of matrine on U937 cells and human umbilical vein endothelial cells proliferation were observed by morphology, MTT and cell cycle detection. RESULTS: U937 cells treated with matrine at the concentration of 0.2 mg/mL to 0.5 mg/mL for 24 h were inhibited proliferation in a time and dose-dependent manner detected by MTT (P0.05 or P0.01) and increased at the S stage (P0.05 or P0.01). The half-inhibition concentration (IC50) was 0.4 mg/mL in U937 cells compared with human umbilical vein endothelial cells (P0.05). HUVECs treated with matrine at the concentration of 0.1 to 0.5 mg/mL for 48 h showed no effect on cell cycle (P0.05). CONCLUSION: Matrine has an inhibited effect on U937 cells proliferation in a time and dose-dependent manner.
Key concepts: Matrine, Umbilical vein, U937 cell, MTT assay, IC50, Chemistry, Cell growth, Human umbilical vein endothelial cell